Potential prognostic biomarkers related to immunity in clear cell renal cell carcinoma using bioinformatic strategy

References

• Wang Q, Zhang H, Chen Q, et al. Identification of METTL14 in kidney renal clear cell carcinoma using bioinformatics analysis. Dis Markers. 2019;2019:5648783.
   PubMed Web of Science ®Google Scholar
• Liang T, Sang S, Shao Q, et al. Abnormal expression and prognostic significance of EPB41L1 in kidney renal clear cell carcinoma based on data mining. Cancer Cell Int. 2020;20:356.
   PubMed Web of Science ®Google Scholar
• Ljungberg B, Bensalah K, Canfield S, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67:913–924.
   PubMed Web of Science ®Google Scholar
• Yu G, Yao W, Wang J, et al. LncRNAs expression signatures of renal clear cell carcinoma revealed by microarray. PLoS One. 2012;7:e42377.
   PubMed Web of Science ®Google Scholar
• Ye Y, Zhang F, Chen Q, et al. LncRNA MALAT1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p/ACVR2B signaling. Mol Carcinog. 2019;58:279–292.
   PubMed Web of Science ®Google Scholar
• Hu Z, Li L, Cheng P, et al. lncRNA MSC-AS1 activates Wnt/beta-catenin signaling pathway to modulate cell proliferation and migration in kidney renal clear cell carcinoma via miR-3924/WNT5A. J Cell Biochem. 2020;121:4085–4093.
   PubMed Web of Science ®Google Scholar
• Chang Y, Li N, Yuan W, et al. LINC00997, a novel long noncoding RNA, contributes to metastasis via regulation of S100A11 in kidney renal clear cell carcinoma. Int J Biochem Cell Biol. 2019;116:105590.
   PubMed Web of Science ®Google Scholar
• Liu H, Ye T, Yang X, et al. A panel of four-lncRNA signature as a potential biomarker for predicting survival in clear cell renal cell carcinoma. J Cancer. 2020;11:4274–4283.
   PubMed Web of Science ®Google Scholar
• Zhu H, Lu J, Zhao H, et al. Functional long noncoding RNAs (lncRNAs) in clear cell kidney carcinoma revealed by reconstruction and comprehensive analysis of the lncRNA-miRNA-mRNA regulatory network. Med Sci Monit. 2018;24:8250–8263.
   PubMed Web of Science ®Google Scholar
• Zhang YP, Cheng YB, Li S, et al. An epithelial-mesenchymal transition-related long non-coding RNA signature to predict overall survival and immune microenvironment in kidney renal clear cell carcinoma. Bioengineered. 2021;12:555–564.
   PubMed Web of Science ®Google Scholar
• Chen J, Jiang CC, Jin L, et al. Regulation of PD-L1: a novel role of pro-survival signalling in cancer. Ann Oncol. 2016;27:409–416.
   PubMed Web of Science ®Google Scholar
• Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.
   PubMed Web of Science ®Google Scholar
• Niemira M, Collin F, Szalkowska A, et al. Molecular signature of subtypes of non-small-cell lung cancer by large-scale transcriptional profiling: identification of key modules and genes by weighted gene co-expression network analysis (WGCNA). Cancers (Basel). 2019;12.
   PubMed Web of Science ®Google Scholar
• Yin L, Cai Z, Zhu B, et al. Identification of key pathways and genes in the dynamic progression of HCC based on WGCNA. Genes (Basel). 2018;9:92.
   PubMed Web of Science ®Google Scholar
• Ren ZH, Shang GP, Wu K, et al. WGCNA co-expression network analysis reveals ILF3-AS1 functions as a CeRNA to regulate PTBP1 expression by sponging miR-29a in gastric cancer. Front Genet. 2020;11:39.
   PubMed Web of Science ®Google Scholar
• Chen M, Yan J, Han Q, et al. Identification of hub-methylated differentially expressed genes in patients with gestational diabetes mellitus by multi-omic WGCNA basing epigenome-wide and transcriptome-wide profiling. J Cell Biochem. 2020;121:3173–3184.
   PubMed Web of Science ®Google Scholar
• Binnewies M, Roberts EW, Kersten K, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24:541–550.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284–287.
   PubMed Web of Science ®Google Scholar
• Favazza L, Chitale DA, Barod R, et al. Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database. Mod Pathol. 2017;30:1603–1612.
   PubMed Web of Science ®Google Scholar
• Liang J, Liu Z, Zou Z, et al. Knockdown of ribosomal protein S15A inhibits human kidney cancer cell growth in vitro and in vivo. Mol Med Rep. 2019;19:1117–1127.
   PubMed Web of Science ®Google Scholar
• Fan L, Li P, Yin Z, et al. Ribosomal s6 protein kinase 4: a prognostic factor for renal cell carcinoma. Br J Cancer. 2013;109:1137–1146.
   PubMed Web of Science ®Google Scholar
• Uzzo RG, Rayman P, Kolenko V, et al. Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells. J Clin Invest. 1999;104:769–776.
   PubMed Web of Science ®Google Scholar
• Finke JH, Rayman P, George R, et al. Tumor-induced sensitivity to apoptosis in T cells from patients with renal cell carcinoma: role of nuclear factor-kappaB suppression. Clin Cancer Res. 2001;7:940s–6s.
   PubMed Web of Science ®Google Scholar
• Menard LC, Fischer P, Kakrecha B, et al. Renal Cell Carcinoma (RCC) tumors display large expansion of Double Positive (DP) CD4+CD8+ T cells with expression of exhaustion markers. Front Immunol. 2018;9:2728.
   PubMed Web of Science ®Google Scholar
• Zhao X, Zhang Z, Li H, et al. Cytokine induced killer cell-based immunotherapies in patients with different stages of renal cell carcinoma. Cancer Lett. 2015;362:192–198.
   PubMed Web of Science ®Google Scholar
• Al Ahmad A, Paffrath V, Clima R, et al. Papillary renal cell carcinomas rewire glutathione metabolism and are deficient in both anabolic glucose synthesis and oxidative phosphorylation. Cancers (Basel). 2019;11:1298.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhao X, Qi J, et al. Eight proteins play critical roles in RCC with bone metastasis via mitochondrial dysfunction. Clin Exp Metastasis. 2015;32:605–622.
   PubMed Web of Science ®Google Scholar
• Cheng Q, Qu D, Lu Z, et al. Knockdown of CHCHD2 inhibits migration and angiogenesis of human renal cell carcinoma: a potential molecular marker for treatment of RCC. Oncol Lett. 2019;17:765–772.
   PubMed Web of Science ®Google Scholar
• Wang L, Qi Y, Wang X, et al. ECHS1 suppresses renal cell carcinoma development through inhibiting mTOR signaling activation. Biomed Pharmacother. 2020;123:109750.
   PubMed Web of Science ®Google Scholar
• Braun DA, Bakouny Z, Hirsch L, et al. Beyond conventional immune-checkpoint inhibition - novel immunotherapies for renal cell carcinoma. Nat Rev Clin Oncol. 2021;18:199–214.
   Web of Science ®Google Scholar
• Xu W, Puligandla M, Manola J, et al. Angiogenic factor and cytokine analysis among patients treated with adjuvant VEGFR TKIs in resected renal cell carcinoma. Clin Cancer Res. 2019;25:6098–6106.
   PubMed Web of Science ®Google Scholar
• Zou A, Liu X, Mai Z, et al. LINC00472 acts as a tumor suppressor in NSCLC through KLLN-mediated p53-signaling pathway via MicroRNA-149-3p and MicroRNA-4270. Mol Ther Nucleic Acids. 2019;17:563–577.
   PubMedGoogle Scholar
• Zhang J, Zhang J, Zhang D, et al. Down-regulation of LINC00472 promotes osteosarcoma tumorigenesis by reducing FOXO1 expressions via miR-300. Cancer Cell Int. 2020;20:100.
   PubMed Web of Science ®Google Scholar
• Deng X, Xiong W, Jiang X, et al. LncRNA LINC00472 regulates cell stiffness and inhibits the migration and invasion of lung adenocarcinoma by binding to YBX1. Cell Death Dis. 2020;11:945.
   PubMed Web of Science ®Google Scholar
• Ye Y, Yang S, Han Y, et al. Linc00472 suppresses proliferation and promotes apoptosis through elevating PDCD4 expression by sponging miR-196a in colorectal cancer. Aging (Albany NY). 2018;10:1523–1533.
   PubMedGoogle Scholar
• Wang YZ, Zhu DY, Xie XM, et al. EA15, MIR22, LINC00472 as diagnostic markers for diabetic kidney disease. J Cell Physiol. 2019;234:8797–8803.
   PubMed Web of Science ®Google Scholar
• Yang Q, Chu W, Yang W, et al. Identification of RNA transcript makers associated with prognosis of kidney renal clear cell carcinoma by a competing endogenous RNA network analysis. Front Genet. 2020;11:540094.
   PubMed Web of Science ®Google Scholar
• Alkhatabi HA, McLornan DP, Kulasekararaj AG, et al. RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis. Oncotarget. 2016;7:47875–47890.
   PubMed Web of Science ®Google Scholar
• Li H, Zhang H, Huang G, et al. Heavy ion radiation-induced DNA damage mediates apoptosis via the Rpl27a-Rpl5-MDM2-p53/E2F1 signaling pathway in mouse spermatogonia. Ecotoxicol Environ Saf. 2020;201:110831.
   PubMed Web of Science ®Google Scholar
• Du W, Sun J, Gu J, et al. Bioinformatics analysis of LINC00426 expression in lung cancer and its correlation with patients’ prognosis. Thorac Cancer. 2020;11:150–155.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang L, Xu Y, et al. Immune-related long noncoding RNA signature for predicting survival and immune checkpoint blockade in hepatocellular carcinoma. J Cell Physiol. 2020;235:9304–9316.
   PubMed Web of Science ®Google Scholar
• Bradburn MJ, Clark TG, Love SB, et al. Survival analysis part II: multivariate data analysis–an introduction to concepts and methods. Br J Cancer. 2003;89:431–436.
   PubMed Web of Science ®Google Scholar
• Kobayashi KS, Chamaillard M, Ogura Y, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science. 2005;307:731–734.
   PubMed Web of Science ®Google Scholar
• Xu D, Zhang S, Zhang S, et al. NOD2 maybe a biomarker for the survival of kidney cancer patients. Oncotarget. 2017;8:101489–101499.
   PubMedGoogle Scholar
• Fukumori T, Takenaka Y, Yoshii T, et al. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. Cancer Res. 2003;63:8302–8311.
   PubMed Web of Science ®Google Scholar
• Peipp M, Kupers H, Saul D, et al. A recombinant CD7-specific single-chain immunotoxin is a potent inducer of apoptosis in acute leukemic T cells. Cancer Res. 2002;62:2848–2855.
   PubMed Web of Science ®Google Scholar
• Peng DH, Rodriguez BL, Diao L, et al. Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8(+) T cell exhaustion. Nat Commun. 2020;11:4520.
   PubMed Web of Science ®Google Scholar
• Miao Y, Wang J, Li Q, et al. Prognostic value and immunological role of PDCD1 gene in pan-cancer. Int Immunopharmacol. 2020;89:107080.
   PubMed Web of Science ®Google Scholar